Pharmacoeconomic evaluation is an analytical tool used with increasing frequency to assist decision making in the financing and management of pharmaceutical products in the health care system or national health insurance programs of an individual country. Pharmacoeconomic (PE) guidelines can be used as a standard for preparation of studies to be included in application for reimbursement, a guide for designing and conducting a study, or a template for evaluating the economic study reports.
This section of the ISPOR website, "Pharmacoeconomic Guidelines Around the World" provides the following:
Guidelines listed are dated based on the publication date of the document and categorized as follows:
COUNTRY-SPECIFIC PHARMACOECONOMIC GUIDELINES
|Published PE Recommendations||PE Guidelines||Submission Guidelines|
MERCOSUR (Argentina, Brazil, Paraguay, Uruguay)
If you would like your country’s pharmacoeconomics guidelines at the ISPOR
website or have comments concerning this section of the ISPOR website, email your request to PEguidelines@ispor.org.
As a reference for the development of this information, please see: Health Care System Information Sharing. The reference citation is: Eldessouki R, Smith MD, Health Care System Information Sharing: A Step Toward Better Health Globally. Value Health Regional Issues 2012; 1:118-129